A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy.
about
Clinical improvement following therapy for periodontitis: Association with a decrease in IL-1 and IL-6.Inflammatory mediators in fluid extracted from the coronal occlusal dentine of trimmed teethEffect of photodynamic therapy, diode laser, and deep scaling on cytokine and acute-phase protein levels in gingival crevicular fluid of residual periodontal pockets.Beneficial effects of hormone replacement therapy on periodontitis are vitamin D associated.Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: a randomized, controlled clinical trial.Influence of smoking on gingival crevicular fluid cytokines in severe chronic periodontitisAdjunctive effect of antimicrobial photodynamic therapy to nonsurgical periodontal treatment in smokers: a randomized clinical trial.Pro-inflammatory, Th1, Th2, Th17 cytokines and dendritic cells: a cross-sectional study in chronic periodontitis.Synergistic anti-inflammatory activity of the antimicrobial peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37) in a three-dimensional co-culture model of gingival epithelial cells and fibroblastsImpact of Chronic Periodontitis on Levels of Glucoregulatory Biomarkers in Gingival Crevicular Fluid of Adults with and without Type 2 Diabetes.Quantitation of SPLUNC1 in saliva with an xMAP particle-based antibody capture and detection immunoassay.Influence of type 2 diabetes on local production of inflammatory molecules in adults with and without chronic periodontitis: a cross-sectional studyIncreased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines.Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects.The effect of low-level laser therapy on non-surgical periodontal treatment: a randomized controlled, single-blind, split-mouth clinical trial.Relationships among interleukin-6, tumor necrosis factor-α, adipokines, vitamin D, and chronic periodontitis.Inflammatory Response Influences Treatment of Localized Aggressive PeriodontitisClopidogrel enhances periodontal repair in rats through decreased inflammation.Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis.How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis?The potential association between gingival crevicular fluid inflammatory mediators and adverse pregnancy outcomes: a systematic review.Oral inflammation, a role for antimicrobial peptide modulation of cytokine and chemokine responses.Clinical and technical considerations in the analysis of gingival crevicular fluid.Gingival crevicular fluid levels of cytokines/chemokines in chronic periodontitis: a meta-analysis.Contribution of proteomics to our understanding of periodontal inflammation.Antimicrobial Activity of Chemokine CXCL10 for Dermal and Oral Microorganisms.Cytokine-based Predictive Models to Estimate the Probability of Chronic Periodontitis: Development of Diagnostic Nomograms.Relationship between periodontal parameters and plasma cytokine profiles in pregnant woman with preterm birth or low birth weight.Clinical response to non-surgical periodontal treatment in patients with interleukin-6 and interleukin-10 polymorphismsDouble-edged-sword effect of IL-1β on the osteogenesis of periodontal ligament stem cells via crosstalk between the NF-κB, MAPK and BMP/Smad signaling pathways.Effect of intra-pregnancy nonsurgical periodontal therapy on inflammatory biomarkers and adverse pregnancy outcomes: a systematic review with meta-analysis.Changes in crevicular cytokines after application of melatonin in patients with periodontal disease.Necessity of keratinized tissues for dental implants: a clinical, immunological, and radiographic study.Local and Plasma Biomarker Profiles in Localized Aggressive Periodontitis.The effect of smoking on inflammatory and bone remodeling markers in gingival crevicular fluid and subgingival microbiota following periodontal therapy.Tumor necrosis factor-α, interleukin-4 and -6 in the serum of health, chronic periodontitis, and type 2 diabetes mellitus.Gingival crevicular fluid and its immune mediators in the proteomic era.Cytokine profile in gingival crevicular fluid and plasma of patients with aggressive periodontitis.Biomarker levels in gingival crevicular fluid of generalized aggressive periodontitis patients after non-surgical periodontal treatment.Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in patients with aggressive periodontitis.
P2860
Q33769585-6592CDF3-2F05-452A-82CB-328A8FE2D4D8Q34022524-7E82F08F-630A-4C99-94F4-02960A845D34Q34105491-F1B43717-78E3-4103-B0D4-EE0BE8A98FD6Q34431707-FD483852-1A44-4F87-AB8B-A387322E132CQ34480601-A183C680-7294-44B4-960C-A4C6C6E84DA5Q34571621-7E3D4BED-540C-4CA1-A37F-C7BD1E2354FAQ34799394-F6499092-004F-407B-B6C1-60041DCE1408Q35132041-248614C6-474F-4C87-96D6-BA51A0DFE509Q35238104-88D09B60-BEA6-475B-91B5-0D7832ED149CQ35628627-2CF7C9CF-6758-4EF3-97D6-FFD028D4F500Q35678284-5E19B28D-DAFF-4DDD-9CF8-E73DEE909A28Q35714040-558BFBC2-B3E7-44E8-B956-FA4E9A14948CQ35737671-8595AE5D-3F4E-4952-9413-1299513BEEA2Q36026074-22D9C212-556F-41F8-BB5A-0553F7CDDDE0Q36103765-CA6D5BA3-F743-495F-B256-28CE7A562D5FQ36919534-21DC327A-2E0E-4D49-9988-C5EA07363092Q37046042-C23BF459-50C5-4CA1-B7E2-8F9DFE75E748Q37634259-D691028F-620C-4CD2-B9F7-4B91DBDBA3A6Q37780267-AC88A51A-C781-4B50-9F7A-9F8EE2CDE0A7Q37842633-280D42E8-0293-4117-97DE-D53D9FA10CE2Q38087292-240FDE8F-364B-4BBB-A571-5A4734E878FFQ38152470-6DBC7CE1-4CBB-4254-8188-0BE6B8A5ED8BQ38667957-F04C5E4E-6791-4D90-83C1-A2FD3D99DDDFQ38793318-B4F44EF4-838D-4FA1-9747-92B775504C27Q39044318-91B5AAF0-8AC4-4D69-BE3D-7A586CCBAA89Q39314294-16F3C737-568D-489C-AAED-8BF011ABC934Q40040037-6E6BD203-6E3A-4191-A8A3-49A68AE1BEE0Q40657607-CE531A0C-8D2A-490B-90A7-B3D6CDB9BF49Q41320668-E3698140-09A0-4E25-A682-82412C247AACQ41875487-F05263DE-FA0C-45BC-B718-4F058DE61335Q42374494-34FD7B62-B177-4A12-811C-FAB4FA3F2BC9Q42662808-9860AF4C-EDEA-4ADF-82F0-E7BE61AB99D3Q43666667-32363751-38EC-400D-A295-EEAF6A5C9FF6Q46227762-79A12FE3-848F-4EEB-BBBA-ED89A84853DDQ46402718-FDD536FB-30A6-427A-9C60-175523D8DE2DQ47151376-C42ACF63-8B55-455B-A004-0F2C13461EA9Q47343603-B3729001-FB1E-4F33-BB2A-4EE897E5DAD5Q47861225-66CFADE0-7159-4863-AC13-6AA346631EB2Q47973124-10CCF679-E08B-42FC-9BAE-1E4331047E3FQ48201575-71380295-0064-44B4-8CD1-AFB715B462D1
P2860
A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A multiplex immunoassay demons ...... g initial periodontal therapy.
@ast
A multiplex immunoassay demons ...... g initial periodontal therapy.
@en
type
label
A multiplex immunoassay demons ...... g initial periodontal therapy.
@ast
A multiplex immunoassay demons ...... g initial periodontal therapy.
@en
prefLabel
A multiplex immunoassay demons ...... g initial periodontal therapy.
@ast
A multiplex immunoassay demons ...... g initial periodontal therapy.
@en
P2093
P2860
P1476
A multiplex immunoassay demons ...... g initial periodontal therapy.
@en
P2093
D H Thunell
G K Johnson
J E Cavanaugh
J M Guthmiller
K A Brogden
K D Tymkiw
K K Burnell
P2860
P304
P356
10.1111/J.1600-0765.2009.01204.X
P577
2009-07-08T00:00:00Z